ERBB2 and breast cancer: Based on our results which indicate that β-HCH exposure increases the metastatic characteristics in the MCF10AT1 cell model and tumor formation in the MMTV-neu mouse model, we conclude that β-HCH can act as a breast cancer promoter via its ability to promote c-Neu overexpression.